GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » AP Biosciences Inc (ROCO:6945) » Definitions » Market Cap

AP Biosciences (ROCO:6945) Market Cap : NT$4,286.79 Mil (As of Dec. 14, 2024)


View and export this data going back to 2023. Start your Free Trial

What is AP Biosciences Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). AP Biosciences's share price for the quarter that ended in Jun. 2024 was NT$58.8. AP Biosciences's Shares Outstanding (EOP) for the quarter that ended in Jun. 2024 was 84.87 Mil. Therefore, AP Biosciences's market cap for the quarter that ended in Jun. 2024 was NT$4,990.41 Mil.

AP Biosciences's quarterly market cap increased from Jun. 2023 (NT$0.00 Mil) to Dec. 2023 (NT$3,017.26 Mil) and increased from Dec. 2023 (NT$3,017.26 Mil) to Jun. 2024 (NT$4,990.41 Mil).

AP Biosciences's annual market cap stayed the same from Dec. 2021 (NT$0.00 Mil) to Dec. 2022 (NT$0.00 Mil) but then increased from Dec. 2022 (NT$0.00 Mil) to Dec. 2023 (NT$3,017.26 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. AP Biosciences's Enterprise Value for Today is NT$2,622.22 Mil.

AP Biosciences Market Cap Historical Data

The historical data trend for AP Biosciences's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AP Biosciences Market Cap Chart

AP Biosciences Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Market Cap
- - - 3,017.26

AP Biosciences Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Market Cap Get a 7-Day Free Trial - - - 3,017.26 4,990.41

Competitive Comparison of AP Biosciences's Market Cap

For the Biotechnology subindustry, AP Biosciences's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

AP Biosciences's Market Cap Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, AP Biosciences's Market Cap distribution charts can be found below:

* The bar in red indicates where AP Biosciences's Market Cap falls into.


AP Biosciences Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

AP Biosciences's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as

Market Cap (A: Dec. 2023 )=Share Price (A: Dec. 2023 )*Shares Outstanding (EOP) (A: Dec. 2023 )
=NT$46.6*64.748
=NT$3,017.26

AP Biosciences's Market Cap for the quarter that ended in Jun. 2024 is calculated as

Market Cap (Q: Jun. 2024 )=Share Price (Q: Jun. 2024 )*Shares Outstanding (EOP) (Q: Jun. 2024 )
=NT$58.8*84.8709
=NT$4,990.41

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

AP Biosciences  (ROCO:6945) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.

AP Biosciences Market Cap Related Terms

Thank you for viewing the detailed overview of AP Biosciences's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.

AP Biosciences Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » AP Biosciences Inc (ROCO:6945) » Definitions » Market Cap
Comparable Companies
ROCO:6461 ROCO:6704 ROCO:4169 ROCO:6926 ROCO:4911 ROCO:4168 ROCO:1777 ROCO:4130 ROCO:4194 ROCO:6733 OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
N/A
Address
No. 3, Park Street, 17th Floor, Taipei, TWN
Website
https://www.apbioinc.com
AP Biosciences Inc is a clinical-stage bispecific antibody new drug research and development company. It has developed a series of antibody and protein lead drugs through a self-designed technology platform for unmet medical needs, focusing on Specific targets associated with diseases to deliver safe, effective and cost-effective medicines.

AP Biosciences Headlines

No Headlines